Pure Global

Typhoid IgG/IgM Antibody Rapid Test - India CDSCO Medical Device Registration

Typhoid IgG/IgM Antibody Rapid Test is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2023/000113_f2f763222f8a2b1aa0036f9b23e18504_435014f9783b164a115771f335c8c59c. This device is marketed under the brand name Chimera. The license holder is CHIMERA BIOTECH PRIVATE LIMITED, and it is classified as Device Class Class B. The approving authority is South Delhi Division.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
Typhoid IgG/IgM Antibody Rapid Test
UID: MFG/IVD/2023/000113_f2f763222f8a2b1aa0036f9b23e18504_435014f9783b164a115771f335c8c59c

Brand Name

Chimera

Device Class

Class B

Approving Authority

South Delhi Division

Product Information

The Chimeraยฎ Typhoid IgG/IgM Rapid Test is a lateral flow immunoassay for the simultaneous detection and differentiation of anti-Salmonella typhi (Chimera) IgG and IgM in human serum or plasma. It is intended to be used as a screening test and as an aid in the diagnosis of infection with S. typhi

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing